Mainstream

Xtant Medical raises 2025 revenue outlook to $131M–$135M as it divests noncore assets and advances biologics platform

Xtant Medical raises 2025 revenue outlook to $131M–$135M as it divests noncore assets and advances biologics platform

Post ContentxtntRead More

You might also be interested in reading Analysts: Gold Transactions Fuel Russian Shadow Trading Payments.

August 12, 2025
In Mainstream